|
Characteristics
| |
|---|
|
Age (years)
|
63.1 ± 7.9
|
|
Sex (male/female)
|
115/ 22
|
|
Ethnicity (Caucasian/non-Caucasian)
|
114/ 23
|
|
BMI (kg/m2)
|
29.2 ± 5.0
|
|
Waist circumference (cm)
|
106 ± 13
|
|
Systolic blood pressure (mmHg)
|
139 ± 17
|
|
Diastolic blood pressure (mmHg)
|
79 ± 9
|
|
Metabolic syndrome¤
|
105 (77%)
|
|
Albuminuria (incl. micro-)
|
34 (25%)
|
|
Current smoker
|
23 (17%)
|
|
Previous myocardial infarction
|
62 (45%)
|
|
Hypertension
|
100 (73%)
|
|
Years of diabetes*
|
9 (5, 15)
|
|
Creatinine (μmol/L)*
|
79 (68, 91)
|
|
LDL (mmol/L)*
|
2.0 (1.6, 2.6)
|
|
HDL (mmol/L)*
|
1.12 (0.94, 1.38)
|
|
Triglycerides (mmol/L)*
|
1.42 (1.06, 1.91)
|
|
HbA1c (%)*
|
7.4 (6.8, 8.3)
|
|
Glucose (mmol/L)*
|
8.1 (6.9, 9.8)
|
|
Insulin (pmol/L)*
|
57 (33, 102)
|
|
C-peptide (pmol/L)*
|
965 (713, 1290)
|
|
HOMA2-IR*
|
1.3 (0.7, 2.1)
|
|
Anti-platelet therapy
|
129 (94%)
|
|
Statin
|
128 (93%)
|
|
Beta-blocker
|
106 (77%)
|
|
ACE-inhibitor/ARB
|
96 (70%)
|
|
Metformin
|
101 (74%)
|
|
Sulfonylurea
|
47 (34%)
|
|
Gliptin
|
17 (12%)
|
|
Insulin/insulin-analogue
|
26 (19%)
|
- Data presented as proportions or mean value ± SD if not otherwise stated.
- ACE; angiotensin converting enzyme. ARB; angiotensin receptor blocker.
- *Median (25, 75 percentiles). ¤International Diabetes Federation, 2006.
